Choose for

All Press Releases All Conference Calls All Shareholder Meetings

Recent Releases

August 03, 2020 17:30:49 ET

RespireRx Pharmaceuticals Inc. (CIK: 849636)

EX-99.5 5 ex99-5.htm Exhibit 99.5AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTThis Amendment No. 1 to Employment Agreement (the “Amendment”), dated as of July 31, 2020, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Timothy Jones (the “Executive”) (together, the “Parties”).WHEREAS, on May 6, 2020, the Parties entered into an Employment Agreement setting f More »

August 03, 2020 17:30:49 ET

RespireRx Pharmaceuticals Inc. (CIK: 849636)

EX-99.1 2 ex99-1.htm Exhibit 99.1EQUITY PURCHASE AGREEMENTThis EQUITY PURCHASE AGREEMENT is entered into as of July 28, 2020 (this “Agreement”), by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the More »

August 03, 2020 17:30:49 ET

RespireRx Pharmaceuticals Inc. (CIK: 849636)

EX-99.2 3 ex99-2.htm Exhibit 99.2REGISTRATION RIGHTS AGREEMENTREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 28, 2020, by and between RespireRx Pharmaceuticals Inc. a Delaware corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have More »

August 03, 2020 17:30:49 ET

RespireRx Pharmaceuticals Inc. (CIK: 849636)

EX-99.3 4 ex99-3.htm Exhibit 99.3NEITHER THESE SECURITIES, NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE, HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES ARE ISSUED IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT More »

August 03, 2020 17:30:49 ET

RespireRx Pharmaceuticals Inc. (CIK: 849636)

EX-99.14 7 ex99-14.htm Exhibit 99.14FIFTH AMENDMENT OF THEAMENDED AND RESTATED RESPIRERX PHARMACEUTICALS INC.2015 STOCK AND STOCK OPTION PLANThis Fifth Amendment (the “Amendment”) of the Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (the “Plan”) of RespireRx Pharmaceuticals Inc. (the “Company”) is made pursuant to a unanimous written consent of the Company’s Board of More »